The company is financially solid, with over $2 billion in cash and healthy profit margins. While the stock isn’t cheap, its ...
Wegovy pill, the first oral GLP-1 for weight loss, is FDA-approved for reducing cardiovascular risks in adults. Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, ...
Packaging firm Klöckner Pentaplast gets court approval to cut €1.3 billion debt and transition to new ownership structure ...
There’s something compelling about stocks you can own for under $30 per share. For investors with $5,000 or less to put into ...
Crown Castle (CCI) has quietly drifted lower over the past few months, even as its underlying tower and fiber business remains central to US wireless networks. That disconnect is where today’s ...
From Viking to Perseverance, scientists have spent decades chasing chemical hints that could point to life beyond Earth.
CleanSpark (CLSK) has quietly outperformed the broader crypto mining group over the past month, gaining about 24% while still sitting below its recent highs, and that disconnect is exactly what makes ...
Built on Inheritance, Not Merit The world is moving from the era of the billionaire to the age of the trillionaire, and the ...
Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...
The Portfolio returned 4.81% gross as resilient consumer spending and potential rate cuts support positive market ...
West Texas parents say racist incidents are going unchecked after the Education Department’s Office for Civil Rights retreated from investigating schools.
Clearwater Analytics (NYSE: CWAN) (“CWAN” or the “Company”), announced that it has entered into a definitive agreement to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results